PubRank

Raymond Vanholder

Author PubWeight™ 284.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acute renal failure. Lancet 2005 5.60
2 EBPG on Vascular Access. Nephrol Dial Transplant 2007 3.26
3 Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014 3.06
4 Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med 2013 2.96
5 The burden of kidney disease: improving global outcomes. Kidney Int 2004 2.94
6 Management of crush-related injuries after disasters. N Engl J Med 2006 2.90
7 Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009 2.89
8 Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2008 2.76
9 EBPG guideline on nutrition. Nephrol Dial Transplant 2007 2.68
10 Acute kidney injury: an increasing global concern. Lancet 2013 2.61
11 Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 2012 2.59
12 Acute kidney injury. Lancet 2008 2.44
13 The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 2005 2.38
14 Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant 2012 2.27
15 Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008 2.24
16 Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant 2006 2.17
17 Noninvasive assessment of local pulse pressure: importance of brachial-to-radial pressure amplification. Hypertension 2005 2.15
18 Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014 2.10
19 Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 2009 2.06
20 The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006 2.01
21 A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012 1.94
22 Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 2009 1.93
23 Chronic kidney disease in adults--UK guidelines for identification, management and referral. Nephrol Dial Transplant 2006 1.91
24 EBPG guideline on dialysis strategies. Nephrol Dial Transplant 2007 1.90
25 Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2013 1.90
26 Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012 1.90
27 Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant 2010 1.90
28 Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010 1.90
29 The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004 1.83
30 Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 2007 1.77
31 Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients. Kidney Int 2013 1.68
32 The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2005 1.67
33 Why less success of the peritoneal dialysis programmes in Europe? Nephrol Dial Transplant 2008 1.65
34 EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 2007 1.65
35 Clinical findings in the renal victims of a catastrophic disaster: the Marmara earthquake. Nephrol Dial Transplant 2002 1.60
36 Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010 1.59
37 Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis 2004 1.58
38 CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl 2008 1.57
39 P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 2006 1.53
40 Severity of sepsis-induced acute kidney injury in a novel mouse model is age dependent. Crit Care Med 2012 1.52
41 Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension 2005 1.52
42 Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J Nephrol 2005 1.51
43 Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant 2010 1.50
44 Acute central hemodynamic effects of a volume exchange in peritoneal dialysis. Perit Dial Int 2008 1.49
45 Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol 2006 1.49
46 Therapeutic interventions favorably influencing delayed and slow graft function in kidney transplantation: mission impossible? Transplantation 2008 1.49
47 The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. Transpl Int 2014 1.48
48 Acute renal failure due to crush syndrome during Marmara earthquake. Am J Kidney Dis 2002 1.47
49 Initiation of dialysis--is the problem solved by NECOSAD? Nephrol Dial Transplant 2002 1.42
50 Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 2010 1.40
51 The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 2007 1.38
52 Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant 2010 1.34
53 The gut: the forgotten organ in uremia? Blood Purif 2010 1.33
54 When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. Nephrol Dial Transplant 2011 1.30
55 Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant 2013 1.28
56 Protein-bound toxins--update 2009. Semin Dial 2009 1.28
57 The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J Am Soc Nephrol 2006 1.25
58 Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 2002 1.24
59 Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 2008 1.23
60 Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant 2008 1.23
61 Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol 2011 1.20
62 Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med 2005 1.19
63 Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 2014 1.17
64 Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney Int 2012 1.16
65 Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 2010 1.16
66 Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension 2011 1.15
67 Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis. Crit Care 2013 1.15
68 Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int 2013 1.15
69 Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation 2005 1.14
70 Warning: the unfortunate end of p-cresol as a uraemic toxin. Nephrol Dial Transplant 2011 1.12
71 An update on the referral pattern of patients with end-stage renal disease. Kidney Int Suppl 2002 1.12
72 Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant 2010 1.11
73 Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant 2003 1.11
74 Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol 2006 1.10
75 Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins. Clin J Am Soc Nephrol 2011 1.10
76 Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 2005 1.09
77 Chronic kidney disease: a European perspective. Kidney Int Suppl 2005 1.07
78 Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artif Organs 2005 1.06
79 Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol 2012 1.05
80 p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol 2013 1.04
81 Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003 1.03
82 Human cytomegalovirus and kidney transplantation: a clinician's update. Am J Kidney Dis 2011 1.03
83 Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant 2014 1.03
84 P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int 2002 1.02
85 Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012 1.00
86 Dialysis water and fluid purity: more than endotoxin. Nephrol Dial Transplant 2012 1.00
87 Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. Nephrol Dial Transplant 2011 1.00
88 Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Diabetes Care 2012 1.00
89 Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant 2010 0.99
90 Guanidino compounds as uremic (neuro)toxins. Semin Dial 2009 0.99
91 Biochemical and clinical evidence for uremic toxicity. Artif Organs 2004 0.99
92 Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. Int J Cardiol 2012 0.97
93 Hypomagnesaemia, the kidney and the vessels. Nephrol Dial Transplant 2012 0.97
94 Management of crush victims in mass disasters: highlights from recently published recommendations. Clin J Am Soc Nephrol 2012 0.97
95 Comparison of different equations to assess glomerular filtration in critically ill patients. Intensive Care Med 2015 0.97
96 Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant 2012 0.97
97 Goodpasture's syndrome associated with autoimmune thrombotic thrombocytopenic purpura an unusual case. Nephrol Dial Transplant 2007 0.96
98 p-cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. Nephrol Dial Transplant 2013 0.95
99 Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. Nephrol Dial Transplant 2010 0.95
100 Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC Med 2014 0.95
101 Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem 2003 0.94
102 Delayed graft function in renal transplantation. Curr Opin Crit Care 2004 0.93
103 New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care 2012 0.93
104 Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone 2007 0.93
105 Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Blood Purif 2010 0.92
106 Efficiency of the Genius batch hemodialysis system with low serum solute concentrations: the case of lithium intoxication therapy. Am J Kidney Dis 2005 0.92
107 Genetics/Genomics in chronic kidney disease--towards personalized medicine? Semin Dial 2009 0.92
108 P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 2004 0.92
109 Early detection of patients at high risk for acute kidney injury during disasters: development of a scoring system based on the Bam earthquake experience. J Nephrol 2008 0.92
110 Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia. Nephrol Dial Transplant 2007 0.92
111 Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis. BMC Nephrol 2015 0.92
112 Application of the RIFLE criteria in patients with crush-related acute kidney injury after mass disasters. Nephrol Dial Transplant 2010 0.92
113 Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice. Nephrol Dial Transplant 2012 0.91
114 Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009 0.91
115 Acute renal problems in the critically ill cancer patient. Curr Opin Crit Care 2008 0.91
116 An overview of morbidity and mortality in patients with acute renal failure due to crush syndrome: the Marmara earthquake experience. Nephrol Dial Transplant 2002 0.91
117 Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients? PLoS One 2013 0.90
118 Platelet/Leukocyte activation, inflammation, and uremia. Semin Dial 2009 0.90
119 Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrol Dial Transplant 2009 0.90
120 Impact of local circumstances on outcome of renal casualties in major disasters. Nephrol Dial Transplant 2008 0.90
121 Epidemiologic aspects of the Bam earthquake in Iran: the nephrologic perspective. Am J Kidney Dis 2006 0.90
122 Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant 2011 0.90
123 A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant 2013 0.89
124 Disaster management of chronic dialysis patients. Am J Disaster Med 2008 0.89
125 Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes. Nephrol Dial Transplant 2007 0.89
126 Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease. PLoS One 2012 0.89
127 Review on uraemic solutes II--variability in reported concentrations: causes and consequences. Nephrol Dial Transplant 2007 0.89
128 Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 2014 0.89
129 Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease. Int J Health Care Finance Econ 2007 0.89
130 Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis. Semin Dial 2014 0.88
131 The relation between salt, volume, and hypertension: clinical evidence for forgotten but still valid basic physiology. Perit Dial Int 2008 0.88
132 Outcome in a post-cardiac surgery population with acute renal failure requiring dialysis: does age make a difference? Nephrol Dial Transplant 2003 0.88
133 Serum urea concentration is probably not related to outcome in ICU patients with AKI and renal replacement therapy. Nephrol Dial Transplant 2011 0.88
134 Is peritoneal dialysis associated with increased cardiovascular morbidity and mortality? Perit Dial Int 2006 0.88
135 Renal Disaster Relief Task Force in Haiti earthquake. Lancet 2010 0.88
136 Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat Rev Nephrol 2012 0.87
137 an Obituary for GFR as the main marker for kidney function? Semin Dial 2011 0.87
138 Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 2010 0.86
139 Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall. J Am Soc Nephrol 2013 0.86
140 Inconsistency of reported uremic toxin concentrations. Artif Organs 2007 0.86
141 A sad but forgotten truth: the story of slow-moving solutes in fast hemodialysis. Semin Dial 2012 0.86
142 In vitro evidence for immune activating effect of specific AGE structures retained in uremia. Kidney Int 2004 0.86
143 European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008 0.86
144 Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation. Nephrol Dial Transplant 2010 0.86
145 When to start dialysis in patients with acute kidney injury? When semantics and logic become entangled with expectations and beliefs. Crit Care 2011 0.85
146 The role of the Renal Disaster Relief Task Force. Nat Clin Pract Nephrol 2008 0.85
147 Pathophysiology of ischaemic acute renal failure. Best Pract Res Clin Anaesthesiol 2004 0.85
148 The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients. Nephrol Dial Transplant 2011 0.85
149 Peritoneal dialysis catheters: the beauty of simplicity or the glamour of technicality? Percutaneous vs surgical placement. Nephrol Dial Transplant 2002 0.85
150 Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization. Nephrol Dial Transplant 2003 0.85
151 New uremic toxins - which solutes should be removed? Contrib Nephrol 2010 0.84
152 Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation. Transplantation 2005 0.84
153 Salt intake induces epithelial-to-mesenchymal transition of the peritoneal membrane in rats. Nephrol Dial Transplant 2010 0.84
154 Features of chronic hemodialysis practice after the Marmara earthquake. J Am Soc Nephrol 2004 0.84
155 A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients. Anal Bioanal Chem 2013 0.84
156 Two-tier approach for the detection of alpha-galactosidase A deficiency in a predominantly female haemodialysis population. Nephrol Dial Transplant 2007 0.84
157 A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test. Nephrol Dial Transplant 2008 0.83
158 Which dialyser membrane to choose? Nephrol Dial Transplant 2004 0.83
159 Renal replacement therapies in the aftermath of the catastrophic Marmara earthquake. Kidney Int 2002 0.83
160 Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes? Clin J Am Soc Nephrol 2009 0.83
161 Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion. Nephrol Dial Transplant 2011 0.83
162 Relation between acute kidney injury and multiple-organ failure: the chicken and the egg question. Crit Care Med 2007 0.83
163 Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration. Nephrol Dial Transplant 2012 0.83
164 Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins. Kidney Int 2003 0.83
165 Peritoneal dialysis in Europe: an analysis of its rise and fall. Blood Purif 2006 0.83
166 Flow cytometric calcium flux assay: evaluation of cytoplasmic calcium kinetics in whole blood leukocytes. J Immunol Methods 2009 0.83
167 Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins? PLoS One 2013 0.83
168 Hypomagnesemia and the risk of new-onset diabetes after liver transplantation. Liver Transpl 2010 0.83
169 Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2011 0.82
170 Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. Proteomics Clin Appl 2011 0.82
171 Loop diuretics for patients with acute renal failure: helpful or harmful? JAMA 2002 0.82
172 Improving salt balance in peritoneal dialysis patients. Perit Dial Int 2005 0.82
173 Bardoxolone methyl, chronic kidney disease, and type 2 diabetes. N Engl J Med 2011 0.82
174 In vitro evaluation of motilin agonism by macrolide immunosuppressive drugs. Nephrol Dial Transplant 2002 0.81
175 The MPO Study: just a European HEMO Study or something very different? Blood Purif 2008 0.81
176 Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clin Chim Acta 2007 0.81
177 The dialytic management of acute renal failure in the elderly. Semin Dial 2002 0.81
178 Uraemic toxins for consideration by the cardiologist-Beyond traditional and non-traditional cardiovascular risk factors. Atherosclerosis 2010 0.81
179 Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant 2007 0.81
180 Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem 2009 0.81
181 When to start chronic dialysis: tunnel vision induced by numbers? Nephrol Dial Transplant 2010 0.81
182 Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest? J Nephrol 2008 0.81
183 Defining acute kidney injury: playing hide-and-seek with the unknown man? Nephrol Dial Transplant 2010 0.81
184 Renal disaster relief: from theory to practice. Nephrol Dial Transplant 2009 0.81
185 Dialysate and blood temperature during hemodialysis: comparing isothermic dialysis with a single-pass batch system. Artif Organs 2010 0.81
186 Lessons learned from the Marmara disaster: Time period under the rubble. Crit Care Med 2002 0.81
187 The role of APD in the improvement of outcomes in an ESRD program. Semin Dial 2002 0.80
188 Association between free light chain levels, and disease progression and mortality in chronic kidney disease. Toxins (Basel) 2013 0.80
189 What guidelines should or should not be: implications for guideline production. Nephrol Dial Transplant 2013 0.80
190 Dialysate partitioning in the Genius batch hemodialysis system: effect of temperature and solute concentration. Kidney Int 2005 0.80
191 Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography. J Biol Inorg Chem 2002 0.80
192 Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients. Nephrol Dial Transplant 2008 0.80
193 Fanconi syndrome in lymphoma patients: report of the first case series. Nephrol Dial Transplant 2010 0.80
194 De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss. Am J Nephrol 2010 0.80
195 We don't need no education ... . (Pink Floyd, The Wall ) Multidisciplinary predialysis education programmes: pass or fail? Nephrol Dial Transplant 2009 0.80
196 What can the dialysis physician learn from kinetic modelling beyond Kt/V(urea)? Nephrol Dial Transplant 2012 0.80
197 Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis. Clin Biochem 2013 0.79
198 [Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease]. Nephrol Ther 2011 0.79
199 Microalbuminuria is more consistent in the presence of cardiovascular risk factors. J Nephrol 2012 0.79
200 Prevention and nondialytic treatment of acute renal failure. Curr Opin Crit Care 2003 0.79
201 Temperature and concentration distribution within the Genius dialysate container. Nephrol Dial Transplant 2007 0.79
202 The fate of older diabetic patients on peritoneal dialysis: myths and mysteries and suggestions for further research. Perit Dial Int 2007 0.79
203 A new initiative in nephrology: 'Kidney disease: improving global outcomes'. Contrib Nephrol 2005 0.79
204 Behaviour of vanadate and vanadium-transferrin complex on different anion-exchange columns. Application to in vivo 48V-labelled rat serum. J Chromatogr B Analyt Technol Biomed Life Sci 2002 0.79
205 Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol 2013 0.79
206 Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst. Nephrol Dial Transplant 2010 0.79
207 The Marmara earthquake: admission laboratory features of patients with nephrological problems. Nephrol Dial Transplant 2002 0.79
208 Genotypes of renin-angiotensin system and plasma adiponectin concentration in kidney transplant patients. Ann Transplant 2013 0.78
209 The relationship of NT-proBNP and dialysis parameters with outcome of incident haemodialysis patients: results from the membrane permeability outcome study. Blood Purif 2013 0.78
210 A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: part 2: renal replacement therapy. Nephrol Dial Transplant 2013 0.78
211 Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial. PLoS One 2010 0.78
212 Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma. Biomaterials 2013 0.78
213 Phosphate metabolism in chronic kidney disease: from pathophysiology to clinical management. Semin Dial 2009 0.78
214 Magnesium and vascular dysfunction in malignant hypertension. Hypertension 2011 0.78
215 Animal models in peritoneal dialysis: a story of kangaroos and ostriches. Perit Dial Int 2006 0.77
216 Internal filtration in a high-flux dialyzer quantified by mean transit time of an albumin-bound indicator. ASAIO J 2013 0.77
217 An infallible recipe? A story of cinnamon, souffle and meta-analysis. Nephrol Dial Transplant 2008 0.77
218 European renal best practice guideline on the management and evaluation of the kidney donor and recipient. Nefrologia 2014 0.77
219 The ultimate salt war? Uraemic toxins are all that count in dialysis patients. Nephrol Dial Transplant 2012 0.77
220 Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis. Nephrol Dial Transplant 2004 0.77
221 Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes. Circ J 2016 0.77
222 All high-flux membranes are equal but some high-flux membranes are less equal than others. Nephrol Dial Transplant 2008 0.77
223 In vivo distribution and fractionation of indium in rats after subcutaneous and oral administration of [(114m)In]InAs. J Environ Monit 2005 0.77
224 Bedside monitoring of anticoagulation in chronic haemodialysis patients treated with tinzaparin. Nephrol Dial Transplant 2013 0.77
225 Hemodialysis as a treatment of severe accidental hypothermia. Artif Organs 2010 0.77
226 Intervention of the renal disaster relief task force (RDRTF) in the Kashmir earthquake. Nephrol Dial Transplant 2006 0.77
227 Dose of dialysis in the intensive care unit: is the venom in the dose or in the clinical experience? Crit Care 2009 0.77
228 Comparative kinetics of the uremic toxin p-cresol versus creatinine in rats with and without renal failure. Kidney Int 2003 0.77
229 Thrombotic microangiopathy: a role for magnesium? Thromb Haemost 2012 0.77
230 Electrolyte disturbances and acute kidney injury in patients with cancer. Semin Nephrol 2010 0.77
231 Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption. Clin Lung Cancer 2012 0.76
232 Peritoneal dialysis in anuric patients: concerns and cautions. Semin Dial 2002 0.76
233 Treatment modalities and outcome of the renal victims of the Marmara earthquake. Nephron 2002 0.76
234 Uremia-related oxidative stress in leukocytes is not triggered by β2-microglobulin. J Ren Nutr 2013 0.76
235 Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis. J Hypertens 2011 0.76
236 Geographical variability of patient characteristics and treatment patterns affect outcomes for incident hemodialysis patients. J Nephrol 2013 0.76
237 Management of crush syndrome casualties after disasters. Rambam Maimonides Med J 2011 0.76
238 How to remove accumulated iodine in burn-injured patients. Nephrol Dial Transplant 2009 0.76
239 Dialysis Duration: The longer the better, but why? [corrected]. Nephrol Dial Transplant 2012 0.76
240 The role of collagen metabolism in CKD-associated arterial senescence: underestimated and underappreciated. Nephrol Dial Transplant 2011 0.76
241 Evolution of protein-bound uraemic solutes during predilution haemofiltration. J Nephrol 2009 0.76
242 Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study. PLoS One 2012 0.76
243 A tantalizing question: Ferrari or Rolls Royce? A meta-analysis on the ideal renal replacement modality for acute kidney injury at the intensive care unit. Crit Care Med 2008 0.76
244 The organization and interventions of the ISN Renal Disaster Relief Task Force. Adv Ren Replace Ther 2003 0.76
245 Marconi revisited: from kidney to brain--two organ systems communicating at long distance. J Am Soc Nephrol 2008 0.76
246 The role of polymer surface degradation and barium sulphate release in the pathogenesis of catheter-related infection. Nephrol Dial Transplant 2009 0.75
247 Effect of gender on various parameters of crush syndrome victims of the Marmara earthquake. J Nephrol 2004 0.75
248 Effects of uremic ultrafiltrate on the regulation of the parathyroid cell cycle by calcitriol. Kidney Int 2003 0.75
249 Dialysis: vascular access: not enough light at the end of the tunnel? Nat Rev Nephrol 2009 0.75
250 Is combined calcium/magnesium phosphate binder really noninferior to sevelamer hydrochloride? Nephrol Dial Transplant 2011 0.75
251 Evidence for internal filtration in the Genius system, performing slow low efficient daily dialysis in the intensive care unit. Blood Purif 2008 0.75
252 European guidelines on when to start dialysis: check the facts first before commenting. Kidney Int 2012 0.75
253 Does urinary neutrophil gelatinase-associated lipocalin really solve the issue of discriminating prerenal from intrinsic acute kidney injury? Kidney Int 2012 0.75
254 Treatment of type 2 diabetes in chronic kidney disease: meekly follow the herd or call to arms? Nephrol Dial Transplant 2009 0.75
255 Hemodialysis: Long weekend hemodialysis intervals--killing fields? Nat Rev Nephrol 2011 0.75
256 Effect of lowering dialysate calcium on bone and mineral parameters related to adynamic bone disease. Ther Apher Dial 2007 0.75
257 In search of the holy grail and the golden fleece. Perit Dial Int 2004 0.75
258 The metabolic syndrome and new-onset diabetes after transplantation: presumed guilty? Transplantation 2010 0.75
259 The patient as a limit to dialysis technology. Clin J Am Soc Nephrol 2011 0.75
260 Dialysate calcium and the European best practice guidelines on hemodynamic instability. Semin Dial 2009 0.75
261 The impact of healthy start peritoneal dialysis on the evolution of residual renal function and nutrition parameters. Adv Perit Dial 2002 0.75
262 Points of Concern in Post Acute Kidney Injury Management. Nephron 2017 0.75
263 Should screening of renal markers be recommended in a working population? Int Urol Nephrol 2014 0.75
264 Chronic kidney disease-related mineral and bone disorders. Nephron Clin Pract 2009 0.75
265 Impact of peritoneal dialysis on patient and graft outcome after kidney transplantation. Contrib Nephrol 2003 0.75
266 Clamping of the dialysate outlet line in the Genius dialysis system does not alter dialysate flow or clearances. Nephrol Dial Transplant 2006 0.75
267 Influence of switching connection ports of double-lumen permanent tunnelled catheters on total solute removal during dialysis. J Nephrol 2011 0.75
268 Comparison of different methods to assess fistula flow. Blood Purif 2010 0.75
269 End-stage disease of native kidneys in a patient with biopsy-proven Arndt-Gottron scleromyxoedema and recurrence in the transplanted kidney. Nephrol Dial Transplant 2007 0.75
270 Fractionation of vanadium in urine of Wistar rats as a function of time after intraperitoneal injection. J Inorg Biochem 2002 0.75
271 Intermittent hemodialysis for acute renal failure patients--an update. Contrib Nephrol 2004 0.75
272 Acute central haemodynamic effects induced by intraperitoneal glucose instillation. Nephrol Dial Transplant 2008 0.75
273 Vitamin D binding protein and the need for vitamin D in hemodialysis patients. J Ren Nutr 2008 0.75
274 Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). J Hypertens 2017 0.75
275 Online hemodiafiltration. Artif Organs 2006 0.75
276 Encapsulating peritoneal sclerosis in a patient with primary hyperoxaluria type 1: a case report. Perit Dial Int 2010 0.75
277 Evaluation of alternatives for dysfunctional double lumen central venous catheters using a two-compartmental mathematical model for different solutes. Int J Artif Organs 2013 0.75
278 Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease. Int J Artif Organs 2012 0.75
279 Prevalence of chronic kidney disease and its risk factors among family practice patients in Lithuania. Clin Nephrol 2012 0.75
280 Slow extended nocturnal home hemodialysis shows superior adequacy compared to in-center dialysis: a mathematical analysis. Blood Purif 2012 0.75
281 Statins for the prevention of contrast-induced acute kidney injury. Curr Opin Nephrol Hypertens 2016 0.75
282 The other side of the coin: impact of toxin generation and nutrition on the uremic syndrome. Semin Dial 2002 0.75
283 The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis. Contrib Nephrol 2017 0.75
284 Peritoneal-dialysis-related peritonitis: the art of rope-dancing. Nephrol Dial Transplant 2002 0.75
285 Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids. Nephrol Dial Transplant 2003 0.75